DERM - Journey Medical Insider Trades Send a Signal | Benzinga
Adam Justin Smith, Director at Journey Medical (NASDAQ:DERM), reported a large insider buy on October 17, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Smith purchased 33,000 shares of Journey Medical. The total transaction amounted to $98,340.
Journey Medical shares are trading down 1.69% at $2.9 at the time of this writing on Wednesday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily to make an investing decision, however an ...